L. Trevor Young mainly investigates Bipolar disorder, Internal medicine, Psychiatry, Endocrinology and Oxidative stress. His Bipolar disorder study combines topics from a wide range of disciplines, such as Psychosocial, Neurotrophic factors and Schizophrenia. His Schizophrenia research integrates issues from Major depressive disorder and Mood disorders.
His research integrates issues of Antidepressant, Gastroenterology and Mood stabilizer in his study of Internal medicine. L. Trevor Young usually deals with Psychiatry and limits it to topics linked to Clinical psychology and Panic disorder, Anxiety disorder, Generalized anxiety disorder, Anxiety and Pharmacotherapy. His work focuses on many connections between Endocrinology and other disciplines, such as Meta-analysis, that overlap with his field of interest in Nitric oxide.
His scientific interests lie mostly in Bipolar disorder, Internal medicine, Endocrinology, Psychiatry and Lithium. L. Trevor Young has researched Bipolar disorder in several fields, including Schizophrenia, Mood disorders and Mood. The Internal medicine study combines topics in areas such as Gastroenterology and Temporal cortex.
When carried out as part of a general Endocrinology research project, his work on Oxidative stress, Pathophysiology and Cerebral cortex is frequently linked to work in Mechanism of action, therefore connecting diverse disciplines of study. As a part of the same scientific study, L. Trevor Young usually deals with the Psychiatry, concentrating on Clinical psychology and frequently concerns with Prevalence of mental disorders. His Lithium research incorporates elements of Genetics, DNA methylation, Mood stabilizer, Lamotrigine and Biochemistry.
His primary scientific interests are in Bipolar disorder, Internal medicine, Endocrinology, Psychiatry and Oxidative stress. His biological study spans a wide range of topics, including Lithium, DNA methylation and Mood. His studies deal with areas such as Gastroenterology and Bipolar I disorder as well as Internal medicine.
His studies examine the connections between Endocrinology and genetics, as well as such issues in Meta-analysis, with regards to Creatine. His research in Psychiatry intersects with topics in Psychotherapist and Hippocampal formation. In general Oxidative stress, his work in Lipid peroxidation and Glutathione peroxidase is often linked to SH-SY5Y linking many areas of study.
His main research concerns Bipolar disorder, Internal medicine, Psychiatry, Endocrinology and Neuroscience. L. Trevor Young has researched Bipolar disorder in several fields, including Genetics, Pharmacogenetics, Genotype, Neuroimaging and Allele. His Internal medicine research is multidisciplinary, relying on both Neuroanatomy and Frontal lobe.
His study on Oxidative stress and Pathophysiology is often connected to Glutamine as part of broader study in Endocrinology. His studies in Neuroscience integrate themes in fields like Glutamate receptor, Neurotrophic factors and Creatine. His Mania study incorporates themes from Quetiapine and Ziprasidone.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.
Biao Chen;Dar Dowlatshahi;Glenda M MacQueen;Jun-Feng Wang.
Biological Psychiatry (2001)
Course of illness, hippocampal function, and hippocampal volume in major depression
Glenda M. MacQueen;Stephanie Campbell;Bruce S. McEwen;Kathryn Macdonald.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
Lakshmi N. Yatham;Sidney H. Kennedy;Sagar V. Parikh;Ayal Schaffer.
Bipolar Disorders (2013)
Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders.
Jeremy W. Gawryluk;Jun-Feng Wang;Ana C. Andreazza;Li Shao.
The International Journal of Neuropsychopharmacology (2011)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.
Lakshmi N Yatham;Sidney H Kennedy;Ayal Schaffer;Sagar V Parikh.
Bipolar Disorders (2009)
Oxidative stress markers in bipolar disorder: a meta-analysis
Ana C. Andreazza;Marcia Kauer-Sant'Anna;Benicio N. Frey;David J. Bond.
Journal of Affective Disorders (2008)
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
Lakshmi N Yatham;Sidney H Kennedy;Claire O'Donovan;Sagar Parikh.
Bipolar Disorders (2005)
Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.
Márcia Kauer-Sant'Anna;Márcia Kauer-Sant'Anna;Flávio Pereira Kapczinski;Ana Cristina Andreazza;Ana Cristina Andreazza;David J. Bond.
The International Journal of Neuropsychopharmacology (2009)
Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder.
Ana C. Andreazza;Li Shao;Jun-Feng Wang;L. Trevor Young.
Archives of General Psychiatry (2010)
A review of psychosocial outcome in patients with bipolar disorder.
Glenda M. MacQueen;L. Trevor Young;Russell T. Joffe.
Acta Psychiatrica Scandinavica (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: